Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 81951 - 81975 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Tretinoin	Approved Investigational Nutraceutical	HTATSF1	27336	downregulated	Tretinoin results in decreased expression of HTATSF1 mRNA	Xq26.3	A24454
Tretinoin	Approved Investigational Nutraceutical	HTR1E	3354	downregulated	Tretinoin results in decreased expression of HTR1E mRNA	6q14.3	A24453
Tretinoin	Approved Investigational Nutraceutical	HTR2C	3358	downregulated	Tretinoin results in decreased expression of HTR2C mRNA	Xq23	A24454
Tretinoin	Approved Investigational Nutraceutical	HTR7	3363	upregulated	Tretinoin results in increased expression of HTR7 mRNA	10q23.31	A24453
Tretinoin	Approved Investigational Nutraceutical	HUNK	30811	upregulated	Tretinoin results in increased expression of HUNK mRNA	21q22.11	A24454
Tretinoin	Approved Investigational Nutraceutical	HYMAI	57061	upregulated	Tretinoin results in increased expression of HYMAI mRNA	6q24.2	A24454
Tretinoin	Approved Investigational Nutraceutical	ICA1	3382	downregulated	Tretinoin results in decreased expression of ICA1 mRNA	7p21.3	A24453
Tretinoin	Approved Investigational Nutraceutical	ICAM1	3383	upregulated	Tretinoin results in increased expression of ICAM1 mRNA	19p13.2	A20711 A24456
Tretinoin	Approved Investigational Nutraceutical	ICAM2	3384	upregulated	Tretinoin results in increased expression of ICAM2 mRNA	17q23.3	A24453
Tretinoin	Approved Investigational Nutraceutical	ICAM3	3385	upregulated	Tretinoin results in increased expression of ICAM3 mRNA	19p13.2	A24376 A24457 A24466
Tretinoin	Approved Investigational Nutraceutical	ICE1	23379	downregulated	Tretinoin results in decreased expression of ICE1 mRNA	5p15.32	A24376
Tretinoin	Approved Investigational Nutraceutical	ID1	3397	upregulated	Tretinoin results in increased expression of ID1 mRNA	20q11.21	A24464 A24455 A24500 A24454 A24453 A24456
Tretinoin	Approved Investigational Nutraceutical	ID2	3398	downregulated	Tretinoin results in decreased expression of ID2 mRNA	2p25.1	A24545
Tretinoin	Approved Investigational Nutraceutical	ID2	3398	upregulated	Tretinoin results in increased expression of ID2 mRNA	2p25.1	A20711 A22307 A24500 A24486 A24466 A24453
Tretinoin	Approved Investigational Nutraceutical	ID3	3399	upregulated	Tretinoin results in increased expression of ID3 mRNA	1p36.12	A24500 A24486 A24453
Tretinoin	Approved Investigational Nutraceutical	IDH1	3417	upregulated	Tretinoin results in increased expression of IDH1 mRNA	2q34	A24456
Tretinoin	Approved Investigational Nutraceutical	IDS	3423	downregulated	Tretinoin results in decreased expression of IDS mRNA	Xq28	A24453
Tretinoin	Approved Investigational Nutraceutical	IDS	3423	upregulated	Tretinoin results in increased expression of IDS mRNA	Xq28	A24456
Tretinoin	Approved Investigational Nutraceutical	IER3	8870	upregulated	Tretinoin results in increased expression of IER3 mRNA	6p21.33	A24376 A24454
Tretinoin	Approved Investigational Nutraceutical	IER5	51278	downregulated	Tretinoin results in decreased expression of IER5 mRNA	1q25.3	A24454
Tretinoin	Approved Investigational Nutraceutical	IFI16	3428	upregulated	Tretinoin results in increased expression of IFI16 mRNA	1q23.1	A24454
Tretinoin	Approved Investigational Nutraceutical	IFI30	10437	upregulated	Tretinoin results in increased expression of IFI30 mRNA	19p13.11	A20711
Tretinoin	Approved Investigational Nutraceutical	IFI35	3430	upregulated	Tretinoin results in increased expression of IFI35 mRNA	17q21.31	A24376
Tretinoin	Approved Investigational Nutraceutical	IFI44	10561	downregulated	Tretinoin results in decreased expression of IFI44 mRNA	1p31.1	A24455
Tretinoin	Approved Investigational Nutraceutical	IFI44	10561	upregulated	Tretinoin results in increased expression of IFI44 mRNA	1p31.1	A24456

Displaying entries 81951 - 81975 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability